Nuveen
IRMD icon

Nuveen’s iRadimed IRMD Stock Holding History

Nuveen’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.89M Sell
61,650
-24,479
-28% -$2.23M ﹤0.01% 2011
2026
Q1 		$8.29M Buy
86,129
+62,767
+269% +$6.28M ﹤0.01% 1660
2025
Q4 		$2.27M Hold
23,362
– – ﹤0.01% 2238
2025
Q3 		$1.66M Hold
23,362
– – ﹤0.01% 2370
2025
Q2 		$1.4M Sell
23,362
-3,653
-14% -$200K ﹤0.01% 2457
2025
Q1 		$1.42M Hold
27,015
– – ﹤0.01% 2481
2024
Q4 		$1.49M Hold
27,015
– – ﹤0.01% 2512
2024
Q3 		$1.36M Buy
27,015
+402
+2% +$18.5K ﹤0.01% 2619
2024
Q2 		$1.17M Hold
26,613
– – ﹤0.01% 2657
2024
Q1 		$1.17M Hold
26,613
– – ﹤0.01% 2635
2023
Q4 		$1.26M Buy
26,613
+3,804
+17% +$160K ﹤0.01% 2617
2023
Q3 		$1.01M Sell
22,809
-4,268
-16% -$198K ﹤0.01% 2568
2023
Q2 		$1.29M Buy
27,077
+12,623
+87% +$569K ﹤0.01% 2542
2023
Q1 		$569K Sell
14,454
-7,660
-35% -$278K ﹤0.01% 2778
2022
Q4 		$625K Sell
22,114
-5,128
-19% -$147K ﹤0.01% 2823
2022
Q3 		$819K Sell
27,242
-1,070
-4% -$37.3K ﹤0.01% 2831
2022
Q2 		$961K Buy
28,312
+5,293
+23% +$190K ﹤0.01% 2796
2022
Q1 		$1.15M Buy
23,019
+3,666
+19% +$170K ﹤0.01% 2765
2021
Q4 		$842K Sell
19,353
-2,625
-12% -$106K ﹤0.01% 2912
2021
Q3 		$733K Sell
21,978
-2,012
-8% -$68.4K ﹤0.01% 3091
2021
Q2 		$705K Buy
23,990
+1,103
+5% +$30.4K ﹤0.01% 3111
2021
Q1 		$590K Sell
22,887
-639
-3% -$15.3K ﹤0.01% 3062
2020
Q4 		$536K Buy
23,526
+551
+2% +$12.7K ﹤0.01% 3028
2020
Q3 		$491K Buy
22,975
+13,726
+148% +$308K ﹤0.01% 2962
2020
Q2 		$215K Buy
+9,249
New +$199K ﹤0.01% 3091
2020
Q1 		– Sell
-71,511
Closed -$1.67M – 3229
2019
Q4 		$1.67M Sell
71,511
-3
-0% -$70 ﹤0.01% 2498
2019
Q3 		$1.5M Buy
+71,514
New +$1.46M ﹤0.01% 2531

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen's IRMD Position: Q2 2026 in Review

Nuveen reduced its iRadimed (IRMD) stake by 28% in Q2 2026, selling an estimated $2.23M and leaving 61,650 shares worth $5.89M. The position accounts for ﹤0.01% of the portfolio, ranked #2011.

Nuveen first reported a position in IRMD in Q3 2019 and has held it in 27 quarters since. The position peaked at $8.29M in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Nuveen held 61,650 shares of iRadimed worth $5.89M as of Q2 2026.
  • Nuveen sold 24,479 iRadimed shares in Q2 2026, an estimated $2.23M.
  • iRadimed made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2011 holding.
  • Nuveen first reported a position in iRadimed in Q3 2019 and has held it in 27 quarters since.
  • Nuveen's iRadimed position peaked at $8.29M in Q1 2026.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.